Trajectories of adiposity indicators and association with asthma and lung function in urban minority children

Stephanie Lovinsky-Desir1, Stephanie J Lussier2, Agustin Calatroni2

  • 1Division of Pediatric Pulmonology, Columbia University Irving Medical Center, Vagelos College of Physicians and Surgeons, New York, NY.

Insights

Childhood adiposity trajectories, including body mass index (BMI) and adipokines, were not linked to asthma development or lung function in a high-risk urban cohort. Further research should explore geographic and socioeconomic factors influencing these relationships.

Area of Science:

  • Pediatric respiratory health
  • Childhood obesity and metabolic health
  • Immunology and environmental exposures

Background:

  • Existing research suggests a link between adiposity and asthma, but early childhood adiposity trajectories in high-risk urban populations remain understudied.
  • Early life trajectories of adipokines, crucial for metabolic and immunologic functions, have not been comprehensively investigated in relation to asthma risk.
  • This study addresses the knowledge gap concerning the relationship between early childhood adiposity patterns and asthma development in vulnerable urban populations.

Purpose of the Study:

  • To characterize longitudinal trajectories of adiposity in a birth cohort of predominantly Black and Latinx children over the first 10 years of life.
  • To investigate the association between observed adiposity trajectories and asthma diagnosis.
  • To examine the relationship between adiposity trajectories and various lung function outcomes, including spirometry and impulse oscillometry.

Main Methods:

  • Longitudinal birth cohort study of 418 predominantly Black and Latinx children in urban US cities.
  • Annual repeated measures of body mass index (BMI) z-score, bioimpedance analysis (percentage of body fat), leptin, and adiponectin.
  • Statistical analysis to identify adiposity trajectories and compare them with asthma diagnosis and lung function parameters (spirometry, impulse oscillometry, methacholine challenge).

Main Results:

  • Three distinct trajectories were identified for BMI z-score, body fat percentage, and leptin levels.
  • Two trajectories were observed for adiponectin levels.
  • No statistically significant association was found between any of the identified adiposity or adipokine trajectories and asthma diagnosis or lung function outcomes.

Conclusions:

  • Early childhood adiposity trajectories, encompassing BMI and key adipokines, were not associated with asthma diagnosis or impaired lung function in this high-risk cohort.
  • The lack of association may be influenced by unique geographic, social, and demographic factors specific to the studied urban populations.
  • Future obesity and asthma research should consider these complex environmental and socioeconomic determinants, particularly in diverse urban settings.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.9K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.4K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
894
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.4K